Medicare Enrolled

Dr. Anjali Bal

Hospitalist Physician · Willow Grove, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2360 MARYLAND RD, Willow Grove, PA 19090
2156576776
In practice since 2015 (11 years)
NPI: 1164818910 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bal

Dr. Anjali Bal is a hospitalist physician in Willow Grove, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Bal performed 63,902 Medicare services across 1,321 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bal received a total of $4,192 from 25 pharmaceutical and/or device companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 0% volume in PA $4,192 industry payments

Medicare Practice Summary

Medicare Utilization ↗
63,902
Medicare services
Top 0% in PA for hospitalist physician
1,321
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,809 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
17,200 $4 $10
Tocilizumab injection (Actemra) 14,800 $5 $7
Denosumab injection (Prolia/Xgeva) 10,380 $18 $27
Romosozumab injection (Evenity) for osteoporosis 8,820 $8 $20
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
6,600 $10 $45
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
3,000 $34 $75
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
1,480 $26 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
476 $99 $240
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
344 $63 $240
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
145 $1 $12
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
122 $112 $688
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
92 $145 $324
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
90 $115 $372
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $68 $158
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
60 $7 $215
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
50 $55 $311
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
46 $24 $237
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
44 $54 $235
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
38 $18 $100
New patient office visit, complex (60-74 min) 26 $184 $466
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.7% high complexity
81.1% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,192
Total received (2021-2024)
Avg $1,048/year across 4 years
Top 3% in PA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
215
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,192 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,997
2023
$1,503
2022
$597
2021
$96

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$323
Amgen Inc.
$193
PFIZER INC.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
E.R. Squibb & Sons, L.L.C.
$133
Radius Health, Inc.
$127
ANI Pharmaceuticals, Inc.
$113
UCB, Inc.
$109
Janssen Biotech, Inc.
$107
Novartis Pharmaceuticals Corporation
$83
AstraZeneca Pharmaceuticals LP
$82
Kyowa Kirin, Inc.
$82
Lilly USA, LLC
$80
Fresenius Kabi USA, LLC
$73
Genentech USA, Inc.
$70
Organon Llc
$52
Mallinckrodt Hospital Products Inc.
$32
Aurinia Pharma U.S., Inc.
$19
Celltrion USA Inc.
$16
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2021-2024) ›
Amgen Inc.
$698
ABBVIE INC.
$424
Janssen Biotech, Inc.
$407
PFIZER INC.
$381
UCB, Inc.
$248
AbbVie Inc.
$239
AstraZeneca Pharmaceuticals LP
$237
Novartis Pharmaceuticals Corporation
$182
E.R. Squibb & Sons, L.L.C.
$180
Aurinia Pharma U.S., Inc.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Lilly USA, LLC
$135
Radius Health, Inc.
$127
ANI Pharmaceuticals, Inc.
$113
Fresenius Kabi USA, LLC
$92
Kyowa Kirin, Inc.
$82
Genentech USA, Inc.
$70
Organon LLC
$60
Organon Llc
$52
Mallinckrodt Hospital Products Inc.
$32
GlaxoSmithKline, LLC.
$30
Kiniksa Pharmaceuticals, Ltd.
$30
GENZYME CORPORATION
$25
Celltrion USA Inc.
$16
Exeltis, USA Inc.
$12
Top 3 companies account for 36.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · HADLIMA · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · OFEV · OJJAARA · ORENCIA · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TAVNEOS · TREMFYA · Tyenne · Tymlos · VEGZELMA · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for hospitalist physician in PA.

Looking for a hospitalist physician in Willow Grove?
Compare hospitalist physicians in the Willow Grove area by procedure volume, costs, and industry payment transparency.
Browse hospitalist physicians nearby

Geographic Context

Hospitalist physicians within 10 mi
364
Per 100K population
42.3
County median income
$111,521
Nearest hospital
JEFFERSON ABINGTON HOSPITAL
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bal is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 3% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bal experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Bal performed 17,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bal receive payments from pharmaceutical companies?
Yes. Dr. Bal received a total of $4,192 from 25 companies across 215 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bal's costs compare to other hospitalist physicians in Willow Grove?
Dr. Bal's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →